01944nam a2200361Ii 4500001001300000003000300013005001700016007001400033008004100047040003300088041000800121043001200129050002100141074001900162086002300181110010700204245025500311264005800566300004400624336000800668337001600676338001900692500003600711500002600747500010600773500002500879504004100904533010700945650006401052650003301116776022501149776020801374ocn853164835BD20161014164142.0he bmb024bbca130718s2012    dcua    bb   f000 0 eng d  aKSWbengerdacKSWdISLdGPO  aspa  an-us---14aKF27b.E553 2010  a1019-B-01 (MF)0 aY 4.C 73/8:111-1301 aUnited States.bCongress.bHouse.bCommittee on Energy and Commerce.bSubcommittee on Health,eauthor.10aPromoting the development of antibiotics and ensuring judicious use in humans :bhearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, June 9, 2010. 1aWashington :bU.S. Government Printing Office,c2012.  avi, 165 pages :billustrations ;c24 cm  btxt  bh2rdamedia  bhe2rdacarrier  aShipping list no.: 2013-0209-M.  a"Serial no. 111-130."  aPaper version available for sale by the Superintendent of Documents, U.S. Government Printing Office.  aCRDP Project record.  aIncludes bibliographical references.  aMicrofiche.b[Washington, D.C.] :cU.S. Government Printing Office,d[2013]e2 microfiches : negative. 0aAntibioticsxDevelopmentxGovernment policyzUnited States. 0aDrug resistancexPrevention.08iPrint version:aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.tPromoting the development of antibiotics and ensuring judicious use in humansw(DLC) 2013379388w(OCoLC)82969835208iOnline version:aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.tPromoting the development of antibiotics and ensuring judicious use in humansw(OCoLC)829703990